Erin Mistry brings 15 years experience in helping manufacturers evaluate their pricing, value and access portfolio strategies across global markets. She is currently Senior Managing Director, Head of Value, Access & HEOR at Syneos Health, a 23,000 + global organization that combines both clinical trial and commercial development services. Erin spent many years working with healthcare systems establishing quality metrics and leading clinical teams that feed into value-based care initiatives and patient engagement strategies while finding the pricing and access niche at Medimmune. She has worked extensively across a variety of therapeutic areas and global markets to build value messaging and demonstration, evidence requirements, pricing strategies, contracting opportunities, and stakeholder engagement plans across the commercial development spectrum. Erin enjoys the dynamic policy environment and the direct interaction with Payer decision makers that influence today’s access decisions.